Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

ASTELLAS PHARMA INC (4503)

10
SummaryChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ASTELLAS PHARMA INC
01:12a MEDIVATION : and Astellas Pharma Releases Results from Phase 2 Terrain Trial
01/23 MEDIVATION : Astellas -enzalutamide phase 2 terrain trial demonstrated statistic..
01/22 ASTELLAS PHARMA : Announces FDA Anti-Infective Drugs Advisory Committee Recommen..
01/14 ASTELLAS PHARMA : Partners With Society of Cardiovascular Patient Care To "Bring..
01/14 ASTELLAS PHARMA : Reports from Astellas Pharma, Inc. Describe Recent Advances in..
01/08 ASTELLAS PHARMA : Reports from Astellas Pharma, Inc. Highlight Recent Findings i..
01/01 ASTELLAS PHARMA : New Findings from Astellas Pharma, Inc. in the Area of Clinica..
01/01 ASTELLAS PHARMA : Studies from Astellas Pharma, Inc. Provide New Data on Type 2 ..
2014 CYTOKINETICS : And astellas announce expansion of collaboration for development ..
2014 ASTELLAS PHARMA : New Findings from Astellas Pharma, Inc. in the Area of Clinica..
2014 ASTELLAS PHARMA : Studies from Astellas Pharma, Inc. Provide New Data on Type 2 ..
2014 ASTELLAS PHARMA : Cytokinetics and Astellas Announce Expansion of Collaboration ..
2014 MEDIVATION : Data presented from phase 2 study of enzalutamide in advanced andro..
2014 ENUMERAL BIOMEDICAL : Appoints Robert L. Van Nostrand to its Board of Directors
2014 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Provide New Insights into ..
2014 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Has Provided New Data on H..
2014 ASTELLAS PHARMA : Data to be presented from phase 2 study of enzalutamide in adv..
2014 ASTELLAS PHARMA : Named to FTSE4Good Sustainability Index for the Third Year
2014 ASTELLAS PHARMA : to end license agreement with Janssen for ASP015K inhibitor
2014 ASTELLAS PHARMA : New Findings from Astellas Pharma, Inc. in Tinea pedis Provide..
2014 ASTELLAS PHARMA : Researchers at Astellas Pharma, Inc. Release New Data on Hemep..
2014DJAbilify Maker Otsuka to Buy Avanir for $3.5 Billion
2014DJAbilify Maker Otsuka to Buy Avanir for $3.5 Billion
2014 ASTELLAS PHARMA : -enzalutamide (xtandi) now approved in europe for the treatmen..
2014 ASTELLAS PHARMA : Announces Personnel Change
2014 ASTELLAS PHARMA : Announces End of License Agreement with Janssen to Develop and..
2014 ASTELLAS PHARMA : Enzalutamide (xtandi) now approved in europe for the treatment..
2014 AMGEN : Astellas announces termination of Amgen-sponsored clinical studies of ri..
2014 ASTELLAS PHARMA : announces termination of Amgen-sponsored clinical studies of r..
2014 ASTELLAS PHARMA : Basilea reports that U.S. FDA sets date of Advisory Committee ..
2014 ASTELLAS PHARMA : opens new regional affiliate office for Middle East, North and..
2014 ASTELLAS PHARMA : Opens New Regional Affiliate Office for Middle East, North and..
2014 ASTELLAS PHARMA : The results of Japanese Clinical Trials of Anti-TNF-alpha Anti..
2014 ASTELLAS PHARMA : Dana-Farber Cancer Institute And Astellas Announce Research Co..
2014 NPS Pharma Names Pierre Legault to Board of Directors
2014 NPS Pharma Appoints Pierre Legault to Board Directors
2014 NPS Pharma Appoints Pierre Legault to Board of Directors
2014 ASTELLAS PHARMA : DANA-FARBER CANCER INSTITUTE AND ASTELLAS ANNOUNCE; Focus on r..
2014 ASTELLAS PHARMA : Changing Tomorrow Day 2014 Marks Astellas' Fifth Annual Global..
2014 ASTELLAS PHARMA : Proteostasis Therapeutics and Astellas Announce Collaboration ..
2014 ASTELLAS PHARMA : DANA-FARBER CANCER INSTITUTE AND ASTELLAS ANNOUNCE - Focus on ..
2014 ASTELLAS PHARMA : Changing Tomorrow Day 2014 Marks Astellas' Fifth Annual Global..
2014 ASTELLAS PHARMA : Europe: XTANDI (Enzalutamide) Capsules Gets Positive CHMP Opin..
2014 ASTELLAS PHARMA : Announces Revision of Dividend Forecast (Increase Dividends) f..
2014 ASTELLAS PHARMA : Qiagen Enters into Agreement with Astellas Pharma
2014 ASTELLAS PHARMA : Announces Revision of Dividend Forecast (Increase Dividends) f..
2014 ASTELLAS PHARMA : Europe's XTANDI (Enzalutamide) Capsules Garners Positive CHMP ..
2014 ASTELLAS PHARMA : -xtandi (enzalutamide) capsules receive positive chmp opinion ..
2014 ASTELLAS PHARMA : Announces Research Collaboration With Harvard Medical School I..
2014 ASTELLAS PHARMA : Teams Up with USA Rugby and Men's Health Network to Encourage ..
2014 ASTELLAS PHARMA : Announces Revision of Package Insert in Japan for XTANDI (enza..
2014 ASTELLAS PHARMA : Announces Revision of Package Insert in Japan for XTANDI® (enz..
2014 ASTELLAS PHARMA : Partners with USA Rugby and Men's Health Network
2014 ASTELLAS PHARMA : and CoMentis to End Agreement to Collaborate on Research, Deve..
2014 ASTELLAS PHARMA : Patent Issued for Nitrogenous-Ring Acylguanidine Derivative
2014 ASTELLAS PHARMA : Announces research collaboration with harvard medical school i..
2014 ASTELLAS PHARMA : ANNOUNCES RESEARCH COLLABORATION WITH HARVARD MEDICAL SCHOOL I..
2014 ASTELLAS PHARMA : Cytokinetics Announces Development Program Update for CK-21271..
2014 ASTELLAS PHARMA : promotes employment of disabled workers with Green Supply Supp..
2014 ASTELLAS PHARMA : promotes employment of people with disabilities by placing the..
2014 ASTELLAS PHARMA : Investigators at Astellas Pharma, Inc. Describe Findings in Ne..
2014 ASTELLAS PHARMA : Agensys Assigned Patent
2014 ASTELLAS PHARMA : Agensys Assigned Patent
2014 ASTELLAS PHARMA : Brian McLellan Promoted To President Of Astellas Pharma Techno..
2014 ASTELLAS PHARMA INC : ex-dividend day for interim dividend
2014 MEDIVATION : and Astellas Pharma: FDA Grants Approval for New Xtandi Indication
2014 ASTELLAS PHARMA : U.S. FDA Approves New Indication for the Use of XTANDI® enzalu..
2014 ASTELLAS PHARMA : has been Selected for the Fourth Consecutive Year for the Dow ..
2014 MEDIVATION : FDA Grants Approval to New Xtandi Indication
2014 ASTELLAS PHARMA : FDA Oks New Indication for the Use of XTANDI (enzalutamide) Ca..
2014 ASTELLAS PHARMA : FDA Approves New Indication for the Use of XTANDI (enzalutamid..
2014 MEDIVATION : ASTELLAS -U.S. FDA Approves New Indication for the Use of XTANDI (e..
2014 ASTELLAS PHARMA : Patent Issued for Antitumor Agent
2014 Swiss Stocks Edge Higher, Led By Drug Makers
2014 ASTELLAS PHARMA : Basilea's partner Astellas receives notification from U.S. FDA..
1  2  3  4  5Next
Advertisement
Chart
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF